New Report: China In Vitro Diagnostics Market Recent Press Release Updates

MarketResearchReports.Biz presents this most up-to-date research on "Research Report On China In Vitro Diagnostics Market" Industry Emerging Opportunities, Trends, Size, Drivers, Strategies, Products And Competitive Landscape, Forecast & Companies Analysis Report 2014

China is gradually becoming a competitive force and evolving into the world’s fastest growing market for In Vitro Diagnostics (IVD) products. By 2018 Chinese IVD market with Billion US$ is expected to be twice more than from its current market size in 2013. Immunoassay has the highest market share compared to all other segments of In Vitro Diagnostics. Clinical Chemistry is in the 2nd position, but its market share is declining year on year, however its market is growing year on year. Molecular Diagnostics holds the 3rd position and its market share is also rising year on year. Roche holds the highest market share in China In Vitro Diagnostics market.

China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis

This is 3rd edition report on In Vitro Diagnostics sector by Renub Research. Report titled “China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis” provides a comprehensive assessment of the fast–evolving, high–growth IVD Market in China. This 77 page report with 34 Figures studies the China IVD market from 4 view points:

Market and Forecast
Segment Wise Market & Forecast
Development Environment & Regulatory Status in China IVD market
Company Wise IVD Sales & Forecast

China IVD Market – Application Segment Analysis (2007 – 2018)

Clinical Chemistry Market
Immunoassay Market
Hematology Market
Coagulation Market
Microbiology Market
Molecular Testing Market
Self Monitoring of Blood Glucose (SMBG) Market
Point of Care Testing (POCT) Market

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/sample/sample/235012

China IVD – Company Wise Sales Analysis (2010 – 2018)

Roche Diagnostic
Sysmex Corporation
Mindray Medical International Limited
Shanghai Kehua Bio–Engineering Co. Ltd.
Others

Profiles of Private Clinical Labs and Diagnostic Services Companies in China

Zhejiang Di’an Diagnostics Technology Co., Ltd
ADICON Clinical Laboratories
Guangzhou Kingmed Diagnostics Center Co. Ltd.
Kindstar Global (Privately held)
BGI–Shenzhen (Privately held)
OriGene Technologies (Privately held)

In Vitro diagnostics (IVD) market plays an integral role in detecting or diagnosing infections or diseases under stringent environments such as a laboratory. IVD industry holds a major role in the disease and healthcare management sector. Due to advances in bioinformatics, genomics, microelectronics, and miniaturization, the past few years have changed dramatically for diagnostic laboratory technology.

For More latest Reports Under Pharmaceutical Market Research Reports Category: http://www.marketresearchreports.biz/category/28

In vitro diagnostics market is highly reliable when it comes to providing valuable information regarding the physiological and/or pathological state of a patient suffering from a disease. This industry has spread its wings into the clinical and traditional medical engineering segments to blend with industry-specific components derived from computer sciences opening up new niche markets for diagnostic testing. IVD is very essential in the clinical domain to take well-informed medical decisions.

For the past 15 years, this market has witnessed number of assays growing in an upswing. IVD has contributed to growth in many medical areas, especially in nucleic acid and immunoassays tests.

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact 
M/s Sheela 
90 Sate Street, Suite 700 
Albany, NY 12207 
Tel: +1-518-618-1030 
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz

Biotechnology: Circulating Tumor Cells (CTC) Technologies Market Recent Press Release Updates

MarketResearchReports.Biz presents this most up-to-date research on "Research Report On Circulating Tumor Cells Technologies Market" Industry Analysis, Size, Share, Growth, Trends and Forecast

This report on Circulating Tumor Cells (CTC) Technologies gives a market insight into technologies and services used for cancer detection. The market is analyzed by Cancer type into Prostate, Breast and Other; and by Function into Prognostics, Diagnostics and Therapy Management. The report serves as a guide to CTC industry, covering more than 150 companies that are engaged in CTC studies/screening, products and services. Major Contract Research Organizations, Research Institutes and Universities serving the CTC market are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to CTC Technologies is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, and Asia-Pacific with 53 exclusive graphically represented exhibits.

To Buy The Copy of This Report Visit:http://www.marketresearchreports.biz/sample/sample/227930

The biggest technical challenge is CTC detection despite the continued development of many new technologies. The key need is for a technology that will detect the real metastasis-initiating CTC which in turn will trigger distant metastases. This may be a combination of complementary technologies or even several technologies optimized for specific tumor types. CTC enrichment depends on the different properties of CTCs that distinguish them from the surrounding normal hematopoietic cells; physical properties; and biological properties. Most of the current technologies are still based on epithelial cell adhesion molecule (EpCAM) expression. New emerging technologies may try to capture EpCAM-negative CTCs. Circulating Tumor Cells (CTCs) are assuming importance as a biomarker for companion diagnostics and early detection for cancer treatment. There are many unmet needs in cancer drug development. Studying of tumor clusters, cell circulation, assessing and correlating types of tumors with their functionalities are vital aspects of CTC studies. Hundreds of clinical studies testify the requirement of detection and molecular characterization of CTCs. Risk estimation, therapy monitoring, identification of targets, and understanding metastatic developments are essential research areas. CTCs are known to represent the biology of cancer, and high counts of CTC lead to negative prognosis. Phenotyping and genotyping CTC and further studies will reveal whether CTC can be used for directing general or targeted anti-cancer therapy.

Table of Content

1. SCOPE AND METHODOLOGY

2. REPORT SYNOPSIS
2.1 Circulating Tumor Cells (CTC) Technologies – Introduction
2.2 Circulating Tumor Cells (CTC) Technologies – Timeline
Biomarkers
CTC as a Biomarker
Process of Metastatic Development, CTCs and Cancer Stem Cells
CTCs in Blood and DTCs in Bone Marrow
Circulating Tumor Cells and Their Clinical Significance
Detection of CTCs and its Significance
Epithelial Mesenchymal Transition
Technologies for Isolation and Characterization of CTCs
CTC and Prostate Cancer
CTC in Breast Cancer
CTCs in Ovarian Cancer
CTC Diagnosis & Prognosis
CTCs as Therapy Response Marker
2.3 Segmentation
Exhibit 1. Segmentation of Global CTC Technologies Market by Cancer Type and by Function
2.4 CTC Technologies - Global Market Analysis
Exhibit 2. CTC Technologies – Global Market Estimations and Predictions (2010-2020) in US$ Billion (Graphical Representation Included)
Exhibit 3. List of Major Global Companies – CTC Technologies

For More latest Reports Under Biotechnology Market Research Reports Category:

The global biotechnology market is closely related to a variety of industries starting from agriculture to medicine. Biotechnology has wide scope in science-based research firms and companies. This field of technology is extensively applied in the area of healthcare and medicine. Several biotechnology related research and development activities are being undertaken by the pharmaceutical industry. Biotechnology contributes significantly to environmental s
in terms of innovations in waste management and environment purification techniques.

High demand for food grains, government incentives and support, and technological advancement for treating fatal diseases are the factors that drive the global biotechnology market. Pharmaco-genomics and bioinformatics are interdisciplinary fields which have stemmed from biotechnology and as a result significant progress has been made in the areas of personalized medicine, drug delivery and drug discovery. In the area of agriculture, biotechnology ensures better crop quality, high crop yield, and better nutritional value of crops. Biotechnology contributes significantly to the coatings industry, and polymer science.

Linkedin

About us

Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

With a team of experienced consultants we are committed to serve our clients in a way which increase their efficiency, reduce costs and saves time. Our professional search engine helps you in finding the best and latest market research report with just one click of the mouse. Our database represents the most updates and latest market research report collections form all the leading market research publishers across the globe.

Green IT And Virtualization Market - Technology Strategic Focus Report

MarketResearchReports.Biz presents this most up-to-date research on "Research Report On Strategic Focus Report - Green IT And Virtualization: Technology And Market Trends" Industry Analysis, Size, Share, Growth, Trends and Forecast

This Strategic Focus report analyses the current trends, drivers, and inhibitors impacting the green IT and virtualization market. The report outlines the evolution of green IT and virtualization technologies, and identifies and assesses the best performing vendors in the market. This report also presents Kable's view of the revenue opportunities in the virtualization market through to 2018, highlighting the market size and growth by technology, geography, sector, and size band. Moreover, following in-depth ICT decision maker surveys, the report outlines enterprises' investment priorities in the virtualization segment.

Green IT And Virtualization

Key Findings

Green IT and virtualization technologies are attracting significant attention from enterprises globally, primarily driven by its advantages relating to cost saving, improved operational efficiency, faster provisioning, and improved disaster recovery.
The importance of virtualization technologies in enterprises is further gaining traction due to the increasing pressure on organizations to improve their efficiency, realize economies of scale, and achieve the maximum utilization of resources.
According to Kable, the top 10 vendors contributed 46.4% of the total green IT and virtualization market size in 2012, with this proportion increasing by 1.7% to reach a figure of 48.1% in 2013.

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/sample/sample/234804

Synopsis

This Strategic Focus report analyses the current trends, drivers, and inhibitors impacting the green IT and virtualization market. The report outlines the evolution of green IT and virtualization technologies, and identifies and assesses the best performing vendors in the market. This report also presents Kable's view of the revenue opportunities in the green IT and virtualization market through to 2018, highlighting the market size and growth by technology, geography, sector and size band. Moreover, following in-depth ICT decision maker surveys, the report outlines enterprises' investment priorities in the virtualization segment.

This product covers the latest trends in the green IT and virtualization market, coupled with insight into the vendor landscape and market size in the virtualization domain.

In particular, it provides an in-depth analysis of the following:

The latest trends impacting the green IT and virtualization market.
The market drivers (both supply-side and demand-side) that will facilitate the growth of the green IT and virtualization market.

The market inhibitors that may hinder the pervasive adoption of green IT and virtualization solutions.
Identification of the top ICT vendors in the virtualization market, coupled with an overview of the top 5 vendors.
The report also covers the primary findings from Kable's view of revenue opportunities in the virtualization market through to 2018, highlighting the market size and growth by technology, geography, sector, and size band.
An identification of enterprises' investment priorities based on their budget allocations relating to green IT and virtualization.

For More latest Reports Under ICT Category: http://www.marketresearchreports.biz/category/96

Reasons To Buy

Helps the reader to understand the green IT and virtualization market landscape, the recent trends, drivers, and inhibitors shaping the green IT and virtualization segment.
The report will provide an assessment of virtualization vendors and their relative performance in the virtualization market.

The most exhaustive and up-to-date report providing revenue opportunity forecasts in the virtualization market from 2014 to 2018, spanning six regions, 14 verticals, and two size bands.
Extensive technology growth predictions based on adoption indicators, end-user technology demand, Kable's in-house ICT survey results, and macroeconomic factors.

The report provides a detailed breakdown of the opportunities within the green IT and virtualization segment and its sub categories.
 

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact 
M/s Sheela 
90 Sate Street, Suite 700 
Albany, NY 12207 
Tel: +1-518-618-1030 
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/

Vanadium Industry: Global & China Market Analysis, Size, Share, Growth, Trends and Forecast

MarketResearchReports.Biz presents this most up-to-date research on "Research Report On Global Vanadium Market" Industry Analysis, Size, Share, Growth, Trends and Forecast 2014

Global Vanadium Industry was a professional and depth research report on Global Vanadium industry that you would know the world's major regional market conditions of Vanadium industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc.

Global and China Vanadium Industry

The report firstly introduced Vanadium basic information including Vanadium definition classification application and industry chain overview; Vanadium industry policy and plan, Vanadium product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.

In the end, the report introduced Vanadium new project SWOT analysis, investment feasibility analysis, and investment return analysis and Global Vanadium industry.

In a word, it was a depth research report on Global Vanadium industry. And thanks to the support and assistance from Vanadium industry chain related technical experts and marketing experts during Research Team survey and interviews.

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/sample/sample/216824

The report including six parts, the first part maainly introduced the product basic information; the second parts mainly analyzed the Asia Vanadium industry; the third part mainly analyzed the North American Vanadium industry; the fourth part mainly analyzed the Europe Vanadium industry; the fifth part mainly analyzed the market entry and investment feasibility; the sixth part was the report conclusion chapter.

Chemicals Market Research Reports

The chemicals market occupies a very significant position in the overall segment of manufacturing. Apart from catering to the daily needs of man, the chemicals market plays a pivotal role in supporting industrial and economic development of a country. The chemicals market is by far the fastest growing segment in the global manufacturing industry. 
In the recent past, the global chemicals market had witnessed a pr
ral change in terms of introduction of innovative technology, greater proliferation of manufacturing centers in the Asia Pacific, emerging markets, and the trend of rising input costs.

For More latest Reports Under Chemicals Category: http://www.marketresearchreports.biz/category/57

Furthermore, the global chemicals market has also been witnessing steep declines in the performance of the specialty and bulk or commodity segments. This has been the consequence of a fall in overall market demand due to the effects of the global economic recession. The economic downturn had adversely affected the demand for chemicals from the developed nations.

However, according to market forecasts, the demand for chemicals will soon be restored in the developed countries. But, on a comparative note, the demand for chemicals generated in the Asian economies is expected to be much more than that of the developed world.

Linkedin

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact 
M/s Sheela 
90 Sate Street, Suite 700 
Albany, NY 12207 
Tel: +1-518-618-1030 
USA: Canada Toll Free: 866-997-4948

MRRBIZ News: Frontier Pharma - NSCLC - Identifying And Commercializing First-In-Class Innovation In Non-Small-Cell Lung Carcinoma

The Report Frontier Pharma - NSCLC - Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz

According to the report, growth in the Non-Small Cell Lung Cancer market will be mainly driven by innovative therapies entering the squamous cell carcinoma market segment. Unlike the non-squamous market segment that currently lacks effective treatment, growth in the NSCLC segment will grow at a moderate Compound Annual Growth Rate (CAGR) of approximately 6.6% till 2020. The value of the Non-Small Cell Lung Cancer (NSCLC) market is expected to grow significantly from US$5.1 billion in 2013 to reach a value of US$7.9 billion in 2020 over the forecast period. This growth will be marked across eight developed nations in the world.

To Read Complete Report with Toc: http://www.marketresearchreports.biz/analysis/228987

The Frontier Pharma - NSCLC - Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma report analyzes innovation in NSCLC segment in the context of the current market landscape and overall pipeline activities. It also includes a comprehensive review of the pipeline for first-in-class therapies, deals surrounding the first-in-class products and analyzes molecule types and molecular target by stage of development. The report also focuses and studies the three main NSCLC subtypes such as squamous cell, adenocarcinoma, and large cell carcinoma.

Studies show that currently the NSCLC pipeline has 389 products that are in an active development stage across various other stages in the global market. However, the Non-Small Cell Lung Cancer (NSCLC) market accrues diversity due to the presence of 122 first-in-class products that accounts for around 38% of the overall pipeline therapies in the market. This poses a stark difference between the range of therapies available in the pipeline and those that the market already comprises of.

The global Frontier Pharma - NSCLC - Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma market finding has strategic implications based on a broad range of market participants. This is due to the market and development landscape that effectively favors first-in-class over non-first-in-class innovation and development in several ways, chiefly through greater revenue and faster approval for both small and large market players.

Nevertheless, despite the high attrition rate in the NSCLC segment, various first-in-class therapies that enter into the market have the potential to improve and transform the NSCLC treatment landscape.

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/228987

From the perspective of First-in-Class Products in Licensing and Co-development Deals, the report discusses a total of 117 first-in-class products that are in the pipeline but have not been entered into the co-development or licensing deal. Although there is low sample size in the market, deals in the first-in-class NSCLC products occur earlier in development as compared to the non-first-in-class counterparts. The NSCLC products also offer a lucrative investment prospect on average and higher deal values. 

The report analysis shows significant variations in the NSCLC first-in-class targets in alignment to frequent gene mutations. It also identifies the in-depth analysis of the most promising first-in-class targets that are based on different scientific and clinical parameters.


Related Reports:

Frontier Pharma: Breast Cancer - Identifying And Commercializing First-In-Class Innovation: http://www.marketresearchreports.biz/analysis/223632

The Report Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz

Exceptionally Large and Innovative Pipeline

The breast cancer pipeline is the largest in the pharmaceutical industry with 815 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape. More pertinently, the degree and proportion of breakthrough innovations in this pipeline is exceptional; GBI Research analysis identified 253 first-in-class programs in the breast cancer pipeline, acting on 176 first-in-class molecular targets. This accounts for some 39% of all products with a disclosed molecular target and is reflective of the high degree of innovation in this indication. This has far-reaching strategic implications for all market participants, as, despite the high attrition rate in breast cancer, it is highly likely many of the first-in-class technologies will reach the market over the coming decade and may transform the clinical and commercial landscape.

Alignment of First-in-Class Molecular Target with Disease Causation
Click Here To Download Detail Report:  http://www.marketresearchreports.biz/sample/sample/223632

One of the key trends in oncology and in breast cancer in particular over the last decade is the clinical and commercial impact of targeted therapies designed to target proteins in signaling pathways that are frequently mutated in a significant proportion of the patient population. By aligning the molecular targets for therapeutic intervention with disease causation and/or propagation, these therapies limit the systemic cytotoxic effects whilst inhibiting tumor-promoting signaling pathways. Such strategies thereby typically achieve superior efficacy and safety profiles.


Frontier Pharma: Psoriasis - Identifying And Commercializing First-In-Class Innovation: http://www.marketresearchreports.biz/analysis/206412

The Report Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz

Psoriasis is a chronic, inflammatory disease triggered by deregulated Thymus-derived (T) cells, resulting inflammation and benign hyperplasia of keratinocytes within the skin. Manifestations of affected skin are red, thickened plaques with an overlying silver-white scale, which significantly impairs the patient’s physical and mental wellbeing. The primary cause of psoriasis is unknown, as are the mechanisms that lead to immune cells directing inflammatory responses towards the skin. Within the lucrative autoimmune market, the psoriasis market has grown considerably due to the repositioning of all three marketed Tumor Necrosis Factor (TNF) inhibitors: Humira (adalimumab) and Enbrel (etanercept) which were originally approved for rheumatoid arthritis, and also Remicade (infliximab), the first biologic to be approved for Crohn’s disease, an autoimmune disease which largely affects the gastrointestinal system.

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/206412

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 The Case for Innovation
2.1 Growing Opportunities for Biologic Products
2.2 Diversification of Molecular Targets
2.3 Innovative First-in-Class Product Developments Remain Attractive
2.4 Changes in the Clinical and Commercial Environment Will be More Favorable to Products That Target Niche Indications and Patient Populations
2.5 Innovation in Psoriasis

For More latest Reports Under Pharmaceutical Market Research Reports Category: http://www.marketresearchreports.biz/category/38

The global pharmaceutical market is almost a trillion dollar industry. The pharmaceutical market has been playing a very important role in the area of scientific advancement and has contributed significantly to economic growth all across the globe. The global pharmaceutical market consists of a wide range of mid-sized, and big companies, and multinational corporations like biopharmaceutical firms, pharmaceutical companies, virtual pharmas, generic manufacturer
biotechnology firms. The pharmaceutical market also includes various service and ancillary support firms which provide raw materials, undertake contract research projects, contract sales, manufacturing technologies, and regulatory guidance.

The global pharmaceutical market is witnessing satisfactory growth owing to factors like high incidence of chronic and contagious diseases, and rising life expectancy. Research and development related investments are also taking place in the pharmaceutical market due to rising demand for innovative and better drugs. An emerging segment in the pharmaceutical market is that of biopharmaceuticals which is extensively applied in proteomics, drug discovery, and genomics.

Next Generation Sequencing Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast

MarketResearchReports.Biz presents this most up-to-date research on "Research Report On Global Next Generation Sequencing Technologies Market" Industry Emerging Opportunities, Trends, Size, Drivers, Strategies, Products And Competitive Landscape Research Report 2020

"Next generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced since the first human genome was sequenced, which took a decade time and around $3 billion. According to experts, in the coming years, a human genome can be sequenced at a cost of $1,000 in one to two days. In the last five years the sequencing cost has rapidly reduced and this is supposed to have a huge impact on the NGS market in the coming years. Until recently, uses of Next Generation Sequencing tools were limited to research Nowadays, NGS technologies have found applications mainly in two fields clinical diagnostics and infectious diseases. This report describes both current and future applications of NGS.

Global Next Generation Sequencing Technologies Market Analysis - Trends & Forecast To 2020

The global Next Generation Sequencing market is poised to grow at a CAGR of more than 20% to reach around $5.0 billion by 2020. The NGS market assessment was made based on products, technologies, end users, applications and geography. The NGS products market is further divided into instruments and reagents, services and workflow products. The instruments and consumables is the largest segment with a share of around half of the market in 2013. The fastest growing segment is the services with a highest CAGR during the forecast period. The major players are interested in services segment as it provides additional revenue for the company at the same time, increases the sales of instruments and reagents.

Browse Full Report With Toc: http://www.marketresearchreports.biz/analysis-details/global-next-generation-sequencing-technologies-market-analysis-trends-and-forecast-to-2020

NGS technology is segmented into targeted resequencing, whole exome sequencing, RNA sequencing, whole genome sequencing, ChIP sequencing, de novo sequencing and methyl sequencing. Among these targeted re-sequencing technology accounted for the largest share of more than 25% of the technology market in 2013 and is expected to grow at a strong CAGR during the forecast period. Whole genome sequencing is poised to grow at the highest CAGR and expected to reach a share of more than 15% of the total market by 2020. Targeted resequencing and whole genome sequencing technologies are the prospective technologies as various targeted disease based NGS assays and panels are emerging and use of personalized medicine transforms with the understanding of individual’s whole genome imprint.

The NGS market by end users is divided into academics, hospitals and clinics, biotech and pharma and other end users, which include nonprofit organizations and commercial labs Out of these end users, academic research holds the largest share of the end user market in 2013. The fastest growing segment is hospitals and clinics which has the highest CAGR during the forecast period. Currently academic institutes dominate the market but hospitals along with clinical laboratories are supposed to be the leading segment in the coming years as clinical NGS applications is rapidly rising.The NGS applications market is classified into clinical and non-clinical applications. By application type, the market is segmented into oncology, genetic screening, infectious diseases, drug & biomarker discovery, molecular epidemiology, agriculture and other applications. Among the overall applications market oncology holds the lions share in 2013, Infectious diseases is expected to grow at the highest CAGR during the forecast period.

To Buy The Copy of This Report Visit:http://www.marketresearchreports.biz/sample/sample/234401

The major factors driving the NGS market include the reduced cost and high speed of NGS technology, increased use in the clinical segment, new application areas of NGS and switch over from microarrays to NGS. However, the standardization of NGS for clinical use, complexity in data interpretation, shortage of skilled labor and dependence of grants and funding for NGS infrastructure are restraining the market growth. The factors such as demand for NGS technology especially in drug discovery and development, growth of personalized medicine using NGS, increased medical spending along with the rise in incidences of chronic diseases are providing opportunities for the market growth.  

Further, the NGS market is segmented by geography into North America, Europe, Asia-pacific and Rest of the World. North America holds the largest share of the global NGS market accounting for around more than 40% in 2013 and Asia-Pacific is the fastest growing region with a CAGR of more than 20% during the forecast period.

The major players operating in the NGS market are Illumina Inc (U.S.), Thermo Fisher Scientific (U.S.), Hoffmann-La Roche Ltd (Switzerland), Pacific Bioscieces (U.S.) Agilent Technologies (U.S.), BGI (Beijing Genomics Institute) (China), Qiagen (Netherlands), Biomatters Ltd (New Zealand), and Genomatix Software GmbH (Germany).

This report provides in-depth market assessment across the major geographies such as:

North America
Europe
Asia-Pacific (APAC)
Rest of the World (RoW)

Reasons to Buy:

Next Generation Sequencing market revenue and market volume 
Next Generation Sequencing market assessment of sequencing runs by end users across the globe 
Key insights on emerging applications in the clinical segment
Major player profiles